Prevention of postoperative nausea and vomiting - A multimodal solution to a persistent problem

New England Journal of Medicine

Volumn 350, Issue 24, 2004, Pages 2511-2512

  White, Paul F ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DROPERIDOL; NEUROKININ 1 RECEPTOR ANTAGONIST; ONDANSETRON; SEROTONIN ANTAGONIST; ANTIEMETIC AGENT; INTRAVENOUS ANESTHETIC AGENT;

AMBULATORY SURGERY; DRUG EFFICACY; DRUG SAFETY; EDITORIAL; HUMAN; POSTOPERATIVE CARE; POSTOPERATIVE NAUSEA; POSTOPERATIVE VOMITING; PRIORITY JOURNAL; PROPHYLAXIS; COST BENEFIT ANALYSIS; DRUG COMBINATION; DRUG INTERACTION; FACTORIAL ANALYSIS; INTRAVENOUS ANESTHESIA; NOTE; POSTOPERATIVE NAUSEA AND VOMITING;

ANESTHESIA, INTRAVENOUS; ANESTHETICS, INTRAVENOUS; ANTIEMETICS; COST-BENEFIT ANALYSIS; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FACTOR ANALYSIS, STATISTICAL; HUMANS; POSTOPERATIVE NAUSEA AND VOMITING; SEROTONIN ANTAGONISTS;

EID: 2942609352     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMe048099     Document Type: Editorial

References (15)

1. Watcha MF, White PF. Postoperative nausea and vomiting: its etiology, treatment, and prevention. Anesthesiology 1992;77:162-84.
2. White PF, Watcha MF. Postoperative nausea and vomiting: prophylaxis versus treatment. Anesth Analg 1999;89:1337-9.
3. Tang J, Wang B, White PF, Watcha MF, Qi J, Wender RH. The effect of timing of ondansetron administration on its efficacy, cost-effectiveness, and cost-benefit as a prophylactic antiemetic in the ambulatory setting. Anesth Analg 1998;86:274-82.
4. Gan TJ, Sloan F, Dear Gde L, El-Moalem HE, Lubarsky DA. How much are patients willing to pay to avoid postoperative nausea and vomiting? Anesth Analg 2001;92:393-400.
5. Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004;350:2441-51.
6. Tang J, Watcha MF, White PF. A comparison of costs and efficacy of ondansetron and droperidol as prophylactic antiemetic therapy for elective outpatient gynecologic procedures. Anesth Analg 1996;83:304-13.
7. Fortney JT, Gan TJ, Graczyk S, et al. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. Anesth Analg 1998;86:731-8.
8. Hill RP, Lubarsky DA, Phillips-Bute B, et al. Cost-effectiveness of prophylactic antiemetic therapy with ondansetron, droperidol, or placebo. Anesthesiology 2000;92:958-67.
9. Tang J, Chen L, White PF, et al. Recovery profile, costs, and patient satisfaction with propofol and sevoflurane for fast-track office-based anesthesia. Anesthesiology 1999;91:253-61.
10. Divatia JV, Vaidya JS, Badwe RA, Hawaldar RW. Omission of nitrous oxide during anesthesia reduces the incidence of postoperative nausea and vomiting: a meta-analysis. Anesthesiology 1996;85:1055-62.
11. White PF. Droperidol: a cost-effective antiemetic for over thirty years. Anesth Analg 2002;95:789-90.
12. Henzi I, Walder B, Tramer MR. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 1999;90:186-94.
13. 3 receptor antagonists beneficial? Anesthesiology 2003;98:293-8.
14. Tang J, White PF, Wender RH, et al. Fast-track office-based anesthesia: a comparison of propofol versus desflurane with antiemetic prophylaxis in spontaneously breathing patients. Anesth Analg 2001;92:95-9.
15. c interval. Anesth Analg 2004;98:1330-5.